NNW Headlines
Save 20% on Press Releases and More with NNW Prime! Click to View Details
Home » NewsRoom » NewsRoom Articles
WednesdayMar 15, 2017 11:00 am

Professional Diversity Net, Inc. (NASDAQ: IPDN) Starts Presentation at 29th Annual Roth Conference

Professional Diversity Net (NASDAQ: IPDN) operates online professional networking communities with career resources in the United States. It operates through three segments, Professional Diversity Network, National Association of Professional Women and Noble Voice Operations. The company serves various cultural groups such as Hispanic-Americans, African-Americans, Asian-Americans, the disabled, military professionals, LBGT communities, plus women’s groups, students and graduates. It offers single and multiple job postings, recruitment media, talent recruitment communities, corporate memberships, hiring campaign marketing and advertising as well as e-newsletter marketing, research and outreach services. For more information, visit the company’s website at www.profusional.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news…

Continue Reading

WednesdayMar 15, 2017 10:44 am

GreeneStone Healthcare Corp. (GRST) Helping Tackle the Effects of Substance Abuse on Young Adults and Children in Florida

Addiction, a chronic brain disease that induces compulsive activity leading to many legal, social, and health consequences, is a problem that has swept over the world. Although this disease may start as a positive experience for the user, the outcome is normally devastating or even fatal. In the U.S., pharmaceutical opioids and heroin are two of the most problematic substances, causing thousands of deaths annually. However, it’s not just opioids and heroin causing problems. Millions of Americans are addicted to other drugs and alcohol. Florida, specifically, is known as a state of hard drinking. It is also known as a…

Continue Reading

WednesdayMar 15, 2017 10:30 am

Mateon Therapeutics, Inc. (NASDAQ: MATN) Starts Presentation at 29th Annual Roth Conference

Mateon Therapeutics (NASDAQ: MATN) is a biopharmaceutical company that focuses on the development of vascular disrupting agents for the treatment of cancer in the United States. Its principal clinical stage product includes fosbretabulin tromethamine, a reversible tubulin binding agent, which has completed Phase II clinical trial for treating recurrent ovarian cancer; and in Phase II clinical trial for treating gastrointestinal neuroendocrine tumors. The company also develops OXi4503 that is in Phase I/II clinical trial stage for treating patients with relapsed or refractory acute myelogenous leukemia or myelodysplastic syndromes. For more information, visit the company’s website at www.mateon.com. About NetworkNewsWire NetworkNewsWire…

Continue Reading

WednesdayMar 15, 2017 10:30 am

KemPharm, Inc. (NASDAQ: KMPH) Starts Presentation at 29th Annual Roth Conference

KemPharm (NASDAQ: KMPH) is a clinical-stage specialty pharmaceutical company that discovers and develops new proprietary prodrugs in the United States. Its advanced product candidate is KP201/APAP, which consists of KP201 prodrug of hydrocodone formulated in combination with acetaminophen (APAP). The company is also developing KP201/APAP as an immediate release (IR) product candidate for the treatment of acute pain, as well as engages in designing KP201/APAP with abuse-deterrent properties to address the epidemic of opioid abuse. The company is also involved in developing KP201/IR (APAP-free), an IR formulation of KP201 without APAP for the short-term management of acute pain. For more…

Continue Reading

WednesdayMar 15, 2017 10:30 am

Cutera, Inc. (NASDAQ: CUTR) Starts Presentation at 29th Annual ROTH Conference

Cutera (NASDAQ: CUTR) is a medical device company that designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems for practitioners worldwide. Since 1998, the Brisbane, California-based company has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue…

Continue Reading

WednesdayMar 15, 2017 10:30 am

Global Self Storage, Inc. (NASDAQ: SELF) Starts Presentation at 29th Annual ROTH Conference

Global Self Storage (NASDAQ: SELF) is a self-administered and self-managed real estate investment trust (“REIT”) focused on the ownership, operation, acquisition, development and redevelopment of self-storage facilities in the United States. The company’s self-storage facilities are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. Global currently owns and operates, through its wholly owned subsidiaries, seven self-storage properties located in New York, Pennsylvania, Illinois, Indiana, and South Carolina. For more information, visit the company’s website at www.globalselfstorage.us. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array…

Continue Reading

WednesdayMar 15, 2017 10:30 am

Cemtrex, Inc. (NASDAQ: CETX) Starts Presentation at 29th Annual ROTH Conference

Cemtrex (NASDAQ: CETX) is a diversified industrial and manufacturing company that provides a wide array of solutions to meet today’s technology challenges. Cemtrex provides manufacturing services of advanced custom engineered electronics, industrial services, monitoring instruments for industrial processes and environmental compliance, and systems for controlling particulates, hazardous gases, emissions of Greenhouse gases, and other regulated pollutants used in emissions trading globally. For more information, visit the company’s website at www.cemtrex.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an…

Continue Reading

WednesdayMar 15, 2017 10:00 am

Mesoblast Ltd. (NASDAQ: MESO) Starts Presentation at 29th Annual Roth Conference

Mesoblast (NASDAQ: MESO) develops cell-based medicines. The company has leveraged its proprietary technology platform based on specialized cells, known as mesenchymal lineage adult stem cells, to establish a portfolio of late-stage product candidates. Its allogeneic off-the-shelf cell product candidates target advanced stages of diseases with high, unmet medical needs including cardiovascular diseases, immune-mediated and inflammatory conditions, orthopaedic disorders, and oncologic/hematologic conditions. Mesoblast’s lead product candidates include MPC-150-IM, a phase 3 product candidate under investigation for the treatment of chronic congestive heart failure; and MPC-06-ID, a phase 3 product candidate under investigation for the treatment of chronic low back pain due…

Continue Reading

WednesdayMar 15, 2017 10:00 am

Microbot Medical, Inc. (NASDAQ: MBOT) Starts Presentation at 29th Annual Roth Conference

Microbot Medical (NASDAQ: MBOT) is a medical device company that engages in the research, design, development, and commercialization of micro-robotics medical technologies. The company’s ViRob and TipCAT platforms consist of micro-robotic technologies, from which the company is developing its product candidates, including the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH); and a self-propelling, semi-disposable endoscope that is being developed initially for use in colonoscopy procedures. The company was founded in 2010 and is based in Yokneam, Israel. For more information, visit the company’s website at www.microbotmedical.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation…

Continue Reading

WednesdayMar 15, 2017 10:00 am

Spotlight Innovation, Inc. (STLT) Starts Presentation at 29th Annual Roth Conference

Spotlight Innovation (OTC: STLT) is a pharmaceutical company that identifies and acquires rights to innovative proprietary technologies designed to address unmet medical needs. It is developing Crotoxin, which is in phase-I clinical trials for the treatment of cancer. The company also focuses on developing and commercializing certain compounds for the treatment of viral infections, including Zika virus infection; STL-182, an orally available small molecule for the treatment of spinal muscular atrophy; and products derived from snake venom that could provide analgesic relief from moderate to severe chronic pain. For more information, visit the company’s website at www.spotlightinnovation.com About NetworkNewsWire NetworkNewsWire…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

NetworkNewsWire

1108 Lavaca St
Suite 110-NNW
Austin, TX 78701
(512) 354-7000

Copyright . NetworkNewsWire® / 1108 Lavaca St Suite 110-NNW Austin, TX 78701 (512) 354-7000 / Disclaimers